For investors seeking U.S. large-cap value exposure, MGV and VTV represent two of the most cost-efficient options available, both issued by Vanguard and both built on indexes from CRSP. Rather than competing as rivals with distinct strategies, these two ETFs sit on the same value spectrum: they share overlapping top holdings, a similar value factor tilt, and a comparable sector footprint. The core difference is breadth. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. This ETF comparison examines how their structural boundaries, sector exposure, and relative positioning translate into different risk, cost, and performance dynamics in the current market environment.
MGV is a passively managed ETF that seeks to track the CRSP U.S. Mega Cap Value Index, a float-adjusted, market-capitalization-weighted benchmark of the largest U.S. companies exhibiting value characteristics. Launched in December 2007, the fund holds approximately 125 stocks, concentrating its exposure in the uppermost tier of the market capitalization spectrum. Its largest positions include Berkshire Hathaway (BRK.B), JPMorgan Chase (JPM), Exxon Mobil (XOM), Johnson & Johnson (JNJ), and Walmart (WMT), with the top ten names representing roughly a quarter of total assets. Sector allocation is led by financials at about 25%, followed by health care (approximately 17%) and industrials (approximately 16%), while technology carries a modest single-digit-to-low-double-digit weight. The fund charges a 0.07% expense ratio and uses a full-replication indexing approach, rebalancing periodically to reflect index changes.
VTV is a passively managed ETF tracking the CRSP U.S. Large Cap Value Index, a broader benchmark that captures large-capitalization U.S. stocks with value characteristics. Introduced in 2004, the fund holds roughly 320 stocks, spanning a wider market-cap range within large caps. Its top holdings overlap heavily with MGV's — including Berkshire Hathaway (BRK.B), JPMorgan Chase (JPM), Exxon Mobil (XOM), and Johnson & Johnson (JNJ) — alongside names such as Chevron (CVX), AbbVie (ABBV), and Micron Technology (MU). Financials lead at roughly 21–23%, with industrials, health care, and energy as the next-largest exposures. At 0.03%, VTV's expense ratio is among the lowest in the value category, and its full-replication methodology keeps tracking tight against the index.
Both funds operate within the large-cap value segment of U.S. equities, a segment that has benefited from renewed investor interest in valuation-sensitive, cash-generating businesses. As markets rotate away from high-multiple growth and mega-cap technology leadership, capital has increasingly flowed toward financials, health care, energy, and industrials — the very sectors that dominate both portfolios. Rising-for-longer interest rate expectations have supported bank earnings, while energy exposure ties returns to commodity pricing. Regulatory scrutiny of technology concentration and shifting monetary policy expectations remain key macro drivers. The principal sector risk for both ETFs is their heavy financials weighting, which makes them sensitive to credit cycles and interest-rate volatility, while their comparatively low technology exposure could lag if growth leadership resumes.
Because both ETFs draw from overlapping value universes, their broad return profiles have historically tracked closely, though their structural differences create subtle performance divergence. VTV's larger, more diversified portfolio includes a wider set of large-cap names and carries a slightly broader technology sleeve, which has at times helped it capture momentum in select semiconductor and hardware names within the value benchmark. MGV's mega-cap focus, by contrast, produces a more concentrated, lower-turnover portfolio with greater single-stock influence from its largest financial and industrial holdings. In recent market cycles, value segments have outperformed as investors favored earnings visibility and dividend income; both funds have participated, with VTV's deeper diversification tending to reduce idiosyncratic volatility relative to MGV's tighter roster. Relative positioning hinges on whether leadership broadens across large caps or remains concentrated in the largest mega-cap names. From what I see, one thing that stands out is how these nuances play out over full cycles.
When I'm screening for ETF ideas or comparing holdings across the value space, Tickeron's AI Screener has become a go-to resource in my workflow. It lets me filter based on technical patterns, fundamentals, and performance metrics to spot how these funds stack up against peers more efficiently than manual reviews alone. This kind of targeted scan helps clarify the diversification and cost trade-offs without adding unnecessary complexity to the process.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
MGV moved below its 50-day moving average on November 18, 2026 date and that indicates a change from an upward trend to a downward trend. In 33 of 44 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 75%.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MGV as a result. In 49 of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 62%.
The Moving Average Convergence Divergence Histogram (MACD) for MGV turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In 37 of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at 70%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MGV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
The RSI Indicator entered the oversold zone -- be on the watch for MGV's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The 10-day moving average for MGV crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 73%.
Following a +1.41% 3-day Advance, the price is estimated to grow further. Considering data from situations where MGV advanced for three days, in 288 of 343 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
MGV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 277 of 353 cases where MGV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows